Vital Signs - Molecular Diagnostics Market Review: Opportunities in Infectious Diseases, Oncology, Carrier Screening, and Prenatal Testing

Vital Signs - Molecular Diagnostics Market Review: Opportunities in Infectious Diseases, Oncology, Carrier Screening, and Prenatal Testing

 

RELEASE DATE
05-Jul-2011
REGION
North America
Research Code: 9561-00-CA-00-00
SKU: HC00628-NA-MR_04101
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00628-NA-MR_04101
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on July 6, 2011, provides a strategic insight on the molecular diagnostics market.

Additionally, a company spotlight is provided for Stratos Genomics, a company that is developing a next generation DNA sequencing technology that enables accurate and ultra-low cost whole genome sequencing non-invasive imaging system that provides automated ultrasound images of the human breast. Reimbursement and regulatory news from the FDA is also provided for week of Jun 6, 2011.

Table of Contents

This week's issue

Related Research
This issue of Vital Signs, released on July 6, 2011, provides a strategic insight on the molecular diagnostics market. Additionally, a company spotlight is provided for Stratos Genomics, a company that is developing a next generation DNA sequencing technology that enables accurate and ultra-low cost whole genome sequencing non-invasive imaging system that provides automated ultrasound images of the human breast. Reimbursement and regulatory news from the FDA is also provided for week of Jun 6, 2011.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-CA-00-00
Is Prebook No